Headquarter of Royal DSM in Heerlen (The Netherlands)
An Iowa ethanol plant that will be one of the first producers of biofuels made from crop waste will be operating by June, Steve Hartig, General Manager for Licensing of POET-DSM Advanced Biofuels, said at the National Ethanol Conference in Orlando, Florida.
POET-DSM, a joint operation between leading U.S. ethanol maker POET LLC and Dutch food and chemicals group DSM, will be among the largest to make so-called advanced biofuels on a commercial scale. The $250 million facility in Emmetsburg, in the north-central part of the No. 1 corn-growing state, will produce 7 million to 12 million gallons of ethanol this year using cobs and other corn “stover”.
Mitsubishi Chemical Corporation, Japanese chemical giant based in Tokyo, announced the development of a new grade of high-performance, high-transparency bio-based engineering plastic called DURABIOTM, using plant-derived isosorbide as its raw material. The new material features excellent optical properties and high resistance to heat and humidity.
Versalis (the chemichal subsidiary of Eni), Industrial Relations Eni and the trade unions have reached an important agreement on the project at the Porto Marghera site (close to Venice) to redesign production facilities and regain competitiveness.
Bio-on, an Italian company founded in 2007 to create 100% natural products based on renewable resources or agricultural processing waste materials, and Magna International Inc., a leading global automotive supplier, have signed a cooperation agreement to start exclusive R&D activities on the use of bioplastics for the automotive industry.
Bio-on has developed a new kind of bioplastic created through the use of naturally occurring bacteria which feed off sugar beet by-products. In the process of fermentation, the material is turned into plastic (polyhydroxyalkanoate or PHA). The result is fully biodegradable in water and soil, an environmentally friendly product that does not rely on food as a natural resource and could provide alternatives to conventional plastics for the automotive industry.
Korean automaker Kia has revealed that the company’s new Soul EV (electric vehicle), which will have its world premiere at the 2014 Chicago Auto Show starting later this week (February 8-17), has achieved UL (Underwriter Laboratoires) Environment validation for bio-based organic carbon content for ten per cent of its interior materials. UL Environment describes itself as a global independent safety science company.
A fuel of the future is being introduced to the streets in a fleet test launched by the joined forces of Clariant, a globally leading specialty chemicals company, based in Muttenz near Basel (Switzerland), Haltermann, one of the leading suppliers of high purity refinery chemicals used in the automotive, pharmaceutical and cosmetics industries, based in Hamburg (Germany), and Mercedes-Benz (Daimler AG). The Clariant sunliquid® process converts wheat straw into cellulosic ethanol. The company Haltermann then mixes the cellulosic ethanol with conventional fuel components to form the new fuel. The production of cellulosic ethanol is virtually CO2-neutral, saving almost 100 % of CO2 emissions when compared to gasoline. Sunliquid®20 is 20 % cellulosic ethanol, i.e. the well-to-wheel comparison shows reductions in greenhouse gas emissions of around 20 % with consistent engine power. There is no competition with food production or for agricultural acreage. A high octane number (RON) of over 100 guarantees optimal efficiency.
Canadian corporation Iogen has developed and patented a new method to make drop-in cellulosic biofuels from biogas using existing refinery assets and production operations. The company estimates there is refining capacity in place to incorporate 5-6 billion gallons per year of renewable hydrogen content into gasoline and diesel fuel. Iogen will initially commercialize the approach using landfill biogas, and then expand production using biogas made in the cellulosic ethanol facilities it is currently developing.
Global Bioenergies, a French company that is developing a process to convert renewable resources into hydrocarbons through fermentation, announces the signature of a collaboration with the German car-manufacturer Audi on the development of isobutene-derived isooctane, a high performance biofuel for gasoline engines.
“The central question for the development of any new field, such as the bioeconomy, is: ‘Who’s going to do it?’ Which countries and which companies are going to make the investments and do the hard development work to achieve the technology and the infrastructure which are necessary to move forward? Technologies are important, feedstocks are important, but at the end of the day it is all about who has the will and motivation to fund and develop these systems”. To say it in this exclusive interview with Il Bioeconomista is Daniel Gibbs, Founder and Ceo of the General Biomass Company, which is currently developing advanced industrial enzymes and other technology to convert nonfood cellulosic feedstocks to sugars for bioplastics, sustainable packaging, renewable chemicals and biofuels. With Gibbs we talk about the bioeconomy in US, the different roles played by America, Europe and Asia, considering the strategic role of cheap nonfood biomass to the further development of the bioeconomy. “We need to realize- says Gibbs – that production of biobased chemicals and plastics from biomass may be a very significant driver of technology development, since the monomers for bioplastics have a higher oxygen content and thus a higher yield than the alkanes needed, e.g., for biojetfuel or biodiesel. Both chemically and financially, this becomes attractive for consumer brands and sustainable packaging
The WordPress.com stats helper monkeys prepared a 2013 annual report for this blog.
Here’s an excerpt:
The concert hall at the Sydney Opera House holds 2,700 people. This blog was viewed about 32,000 times in 2013. If it were a concert at Sydney Opera House, it would take about 12 sold-out performances for that many people to see it.
IL BIOECONOMISTA 